Achaogen Obtains $56,000,000 Series C Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b74e761f-eca3-4e3f-9ce8-4fe08f4569e5&Preview=1 -
Date
4/7/2010 -
Company Name
Achaogen -
Mailing Address
7000 Shoreline Court South San Francisco, CA 94080 -
Company Description
Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular. -
Website
http://www.achaogen.com
-
Transaction Type
Venture Equity -
Transaction Amount
$56,000,000 -
Transaction Round
Series C -
Proceeds Purposes
Our mission is to discover and develop life-saving antibiotics. This financing together with non-dilutive capital that we have secured through partnerships with various government agencies will enable us to advance multiple clinical programs, including conducting a Phase 2 study in complicated urinary tract infections of ACHN-490, our lead candidate for multi-drug resistant bacterial infections. -
M&A Terms
-
Venture Investor
Frazier Healthcare Ventures -
Venture Investor
Alta Partners -
Venture Investor
5AM Ventures -
Venture Investor
ARCH Venture Partners -
Venture Investor
Domain Associates -
Venture Investor
Venrock -
Venture Investor
Versant Ventures -
Venture Investor
Undisclosed
